Physician
Children's Clinic of El Paso
Children's Clinic of El Paso was paid $2.67M by Medicaid between Sep 2020 and Dec 2024, across 70 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 18% of everything it billed.
33Billing provider infoCHILDREN'S CLINIC OF EL PASO
EL PASO, TX 79936
EL PASO, TX 79936
33aNPI1841336716assigned 01/29/2007
33bProvider typePediatrics Physician
28Total paid$2.67M
24GClaims96,891
24DCodes billed70
24AFirst – last monthSep 2020 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Texas
Rank by total paid#178 of 1,136
Median peer was paid$329K
This provider vs. median8.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 3,432 | $71K | |
| 2021 | 22,287 | $518K | |
| 2022 | 23,320 | $580K | |
| 2023 | 24,836 | $757K | |
| 2024incomplete | 23,016 | $743K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 18% | 12,511 | 11,660 | $492K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 17% | 8,311 | 7,731 | $456K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 11% | 3,558 | 3,529 | $288K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 10% | 3,132 | 3,108 | $267K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 9.7% | 2,924 | 2,906 | $259K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 9.3% | 3,105 | 2,937 | $249K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 7.3% | 16,743 | 7,152 | $195K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.5% | 1,468 | 1,449 | $66K |
| 99429 | 2.2% | 1,656 | 1,630 | $58K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.9% | 5,957 | 4,915 | $52K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.9% | 3,582 | 3,487 | $51K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.4% | 2,561 | 1,253 | $37K |
58 more codes
| 99203 | Doctor's office visit, new patient (routine) | 1.2% | 507 | $33K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 906 | $23K |
| 99383 | <1% | 238 | $23K | |
| 90461 | <1% | 4,896 | $18K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,434 | $17K |
| 99384 | <1% | 144 | $14K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 267 | $13K |
| 99382 | <1% | 88 | $8K | |
| S8301 | Infection control supplies, not otherwise specified | <1% | 2,521 | $8K |
| 96160 | <1% | 3,271 | $7K | |
| 99463 | <1% | 65 | $7K | |
| 99381 | <1% | 80 | $6K | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 381 | $5K |
| 83655 | <1% | 243 | $3K | |
| 90671 | <1% | 924 | $2K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 22 | $2K |
| 90480 | <1% | 62 | $2K | |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | <1% | 79 | $2K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 73 | $1K |
| 99000 | <1% | 77 | $893.20 | |
| 97802 | <1% | 125 | $888.00 | |
| 90697 | <1% | 586 | $714.00 | |
| 96380 | <1% | 35 | $660.98 | |
| 90619 | <1% | 587 | $587.78 | |
| 90680 | <1% | 1,621 | $349.01 | |
| 81002 | <1% | 113 | $341.71 | |
| 90633 | <1% | 1,278 | $287.60 | |
| 90651 | <1% | 1,051 | $185.23 | |
| G9716 | Bmi is documented as being outside of normal parameters, follow-up plan is not completed for documented medical reason | <1% | 29 | $180.00 |
| 90656 | <1% | 501 | $179.03 | |
| 91322 | <1% | 29 | $160.62 | |
| 92551 | <1% | 56 | $75.33 | |
| 87420 | <1% | 44 | $70.08 | |
| 90686 | <1% | 2,826 | $67.60 | |
| 85018 | <1% | 49 | $41.10 | |
| 99001 | <1% | 42 | $37.80 | |
| 94760 | <1% | 252 | $26.75 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 57 | $3.16 |
| 90716 | <1% | 292 | $0.02 | |
| 90677 | <1% | 29 | $0.02 | |
| 90707 | <1% | 295 | $0.02 | |
| 90670 | <1% | 1,415 | $0.01 | |
| 90744 | 0% | 90 | $0.00 | |
| 36416 | 0% | 207 | $0.00 | |
| 90723 | 0% | 584 | $0.00 | |
| 90620 | 0% | 13 | $0.00 | |
| 90696 | 0% | 199 | $0.00 | |
| 90698 | 0% | 355 | $0.00 | |
| 90381 | 0% | 14 | $0.00 | |
| 90648 | 0% | 941 | $0.00 | |
| 90700 | 0% | 397 | $0.00 | |
| 90715 | 0% | 276 | $0.00 | |
| 90734 | 0% | 379 | $0.00 | |
| 90672 | 0% | 12 | $0.00 | |
| 90710 | 0% | 225 | $0.00 | |
| 99173 | 0% | 56 | $0.00 | |
| 90380 | 0% | 12 | $0.00 | |
| 91321 | 0% | 33 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialAZARCON-SAMONTE, PATRICIA (PRESIDENT)